NCT05233397 2026-03-02ACTEMRA® for the Treatment of Pediatric Adamantinomatous CraniopharyngiomaNationwide Children's HospitalPhase 2 Recruiting38 enrolled
NCT04729959 2025-10-20Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent GlioblastomaNational Cancer Institute (NCI)Phase 2 Active not recruiting59 enrolled